Observing gestational diabetes in pregnant women
Official title: German Study Gestational Diabetes (PREG)
Run by University Hospital Tuebingen · NCT04270578 · Data updated 2026-11-12
This study looks at how common gestational diabetes is in pregnant women and what factors may increase the risk, aiming to improve care for moms and their babies.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 800 (estimated) |
| Sponsor | University Hospital Tuebingen Academic / other |
| Locations | 1 site (Tübingen) |
| Status | Recruiting |
| Started | May 23, 2012 |
| Main results expected | May 1, 2027 |
| Study ends | May 1, 2028 |
| Registry record updated | August 22, 2022 |
| Trial ID | NCT04270578 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are pregnant women between 24 and 31 weeks of gestation who have a documented occurrence of GDM in a previous pregnancy.
✕Probably not a fit
Patients with pre-existing diabetes mellitus, significant renal impairment, or certain psychiatric disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to monitor and understand the prevalence and implications of gestational diabetes mellitus (GDM) among pregnant women. It focuses on identifying risk factors such as maternal age and weight gain during pregnancy, as well as the socio-economic consequences of diabetes. Participants will be enrolled during pregnancy or postpartum, provided they meet specific inclusion criteria. The study seeks to enhance early detection and management of GDM to improve health outcomes for mothers and their children.
Why it matters
Potential benefit: If successful, this study could lead to improved early detection and management of gestational diabetes, reducing complications for mothers and infants.
How similar studies have gone: Other studies have shown success in managing gestational diabetes through early detection and lifestyle interventions, indicating that this approach is supported by existing research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Signed and dated informed consent Enrollment is possible during AND after gestation: * Baseline visit (pregnancy): gestational week 24+0 till 31+6 * Postpartum visits: documented occurence of GDM in previous pregnancy Exclusion Criteria: * Age \< 18years * Diabetes Mellitus Type 1 or Type 2 * GFR \< 60 ml/min/1,73 m2 * CRP \> 1 mg/dl * Increased levels of transaminases 2 fold above ULN * Preexisting cardiac conditions * Weight loss \> 10% within 6 months prior to inclusion * Psychiatric disorders * Chronic alcohol or substance abuse * Blood sugar increasing or decreasing drug therapy, e.g. steroids, antidiabetics, insulin * only postpartum visits: pregnancy or lactation
Where it's running
-
University Hospital Tuebingen
Tübingen, Germany Recruiting
Study contacts
- Principal investigator: Andreas Fritsche, MD — University Hospital Tuebingen
- Study coordinator: Andreas Fritsche, MD
- Email: andreas.fritsche@med.uni-tuebingen.de
- Phone: +49 7071 29
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Early Glucose Patterns in Pregnant Women at Risk for GDM
This study tests whether continuous glucose monitoring in early pregnancy can detect dysglycemia before GDM is diagnosed, in women with and without known risk factors.
-
Probiotic-augmented therapy for gestational diabetes
This trial tests whether adding multistrain probiotics to metformin, insulin, or their combination can improve blood sugar control and inflammation in pregnant women with gestational diabetes.
-
Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes
This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.
-
How sleep, lifestyle, and metabolism relate to pregnancy outcomes in gestational diabetes
This project will see if sleep quality, anxiety, eating and activity habits, and metabolic markers relate to blood sugar control and birth outcomes in pregnant people with gestational diabetes.
-
Pre-eclampsia risk in pregnancies after oocyte donation
We will follow pregnant women who used donated eggs and women who used their own eggs to see if pregnancies after oocyte donation lead to a higher risk of pre-eclampsia.
-
Mobile-based obstetric monitoring for hypertension and diabetes during pregnancy
A mobile app-based program lets pregnant people with high blood pressure or gestational diabetes track BP and glucose at home and share results with their care team to guide care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.